An interventional study of Treatment group T1 in Hyperlipidaemia, Liver Biomarkers and Weight Change, sponsored by University of Lahore. Completed at 1 site in Pakistan. Open to participants aged 45 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-31.
Sponsored by University of Lahore · Not applicable, Interventional, and Health services research
Cinnamon-enriched cookies were developed and evaluated for their sensory acceptability and potential as a functional food for adults with hyperlipidemia. The findings suggest that incorporating cinnamon into cookies alongside conventional therapy may support cardiovascular and liver health while offering a palatable dietary intervention.
This study developed cinnamon-enriched cookies as a functional food and evaluated their sensory acceptability, physical characteristics, and potential health benefits in adults with hyperlipidemia receiving conventional therapy. The findings highlight the potential of cinnamon-enriched cookies as a convenient, acceptable, and food-based dietary strategy to support cardiovascular and liver health, encouraging the development of functional bakery products for managing hyperlipidemia.
1,175 studies on the registry are indexed under Hypercholesterolemia; 93 are open to participants now.
This study's enrollment of 40 is below the median of 110 across 975 interventional studies indexed under Hypercholesterolemia.
Browse Hypercholesterolemia studies →University of Lahore is the lead sponsor of 232 studies on the registry; 41 are open to participants now.
Compared within Hypercholesterolemia, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Hyperlipidemias. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Both men and women aged 45-55 participated in the study. The experiment targeted high-cholesterol, triglycerides, and low-density lipoprotein patients (>220, 150, and 130 mg/dL).
Exclusion Criteria:
Individuals with diabetes, gastrointestinal issues, documented cinnamon allergies were excluded.
-
Conventional therapy + whole-wheat cookie once a day
Dietary Supplement: Treatment group T1
Conventional therapy + cinnamon-enriched cookie (1 cookie/day)
Anthropometric measurement
Weight, BMI was measured
Time frame: 10 weeks
Lipid Profile
Lipid Profile was observed
Time frame: 10 weeks
Liver Enzymes
Liver Enzymes were observed
Time frame: 10 weeks
Plan to share: No
Ran from May 2024 to primary completion in Jun 2024, 1 month.
Of 133 non-industry interventional studies with no phase under Hypercholesterolemia, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 36. This study's 1 month is below that.
Counting every sponsor, half of 151 studies reached it within 15 months; a quarter within 6 and three quarters within 35.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.